A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches
Abstract Background Glioblastoma multiforme (GBM) is a lethal brain tumor. With the current gold standard chemotherapy treatment, temozolomide (TMZ), many patients do not survive beyond one year. While the urgency of researching novel treatments is understandable, the prohibitively high costs and th...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Clinical Epigenetics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13148-025-01900-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850113025539833856 |
|---|---|
| author | Meijun Liu Yuying Wang Xiaoli Chen Yu Zeng Wenqiong Huang Jiawen Yang Hong Dai Lixin Cheng Claudio Mauro Kenneth Chat Pan Cheung |
| author_facet | Meijun Liu Yuying Wang Xiaoli Chen Yu Zeng Wenqiong Huang Jiawen Yang Hong Dai Lixin Cheng Claudio Mauro Kenneth Chat Pan Cheung |
| author_sort | Meijun Liu |
| collection | DOAJ |
| description | Abstract Background Glioblastoma multiforme (GBM) is a lethal brain tumor. With the current gold standard chemotherapy treatment, temozolomide (TMZ), many patients do not survive beyond one year. While the urgency of researching novel treatments is understandable, the prohibitively high costs and the prolonged duration of research and clinical trials significantly delay the availability of medical advancements to the general public. This highlights the urgent need for adjuvant therapies to enhance treatment effectiveness. Main body: Recent research has suggested the potential of repurposing FDA-approved drugs such as temozolomide (TMZ), disulfiram (DSF), and aspirin for the treatment of glioblastoma, with encouraging evidence particularly for DSF and aspirin. Additionally, compounds like histone deacetylase inhibitors (e.g., vorinostat) are being investigated for their impact on non-coding RNA (ncRNA) modulation, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). Combining traditional therapies with ncRNA modulation has shown potential in enhancing therapeutic efficacy and targeting specificity. NcRNAs play a crucial role in regulating gene expression and have been implicated in tumor growth, invasion, and treatment resistance. Recent discoveries, such as cuproptosis, offer new insights into tumor cell death mechanisms. Conclusion This review focuses on how these molecular insights can serve as novel therapeutic targets and how drug adjuvant therapy may improve GBM treatment strategies. It focuses on how the integration of ncRNA modulation with conventional therapies and the combination strategy of enhancing efficacy of drugs can enhance treatment efficacy and pave the way for innovative approaches in managing GBM. In short, we will explore how non-coding RNAs (ncRNAs) might serve as promising targets and how repurposing TMZ, DSF, and aspirin could help enhance the efficacy of GBM treatment. Graphical abstract |
| format | Article |
| id | doaj-art-a1d1ec596f534772b3eb1cfaadb34820 |
| institution | OA Journals |
| issn | 1868-7083 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Clinical Epigenetics |
| spelling | doaj-art-a1d1ec596f534772b3eb1cfaadb348202025-08-20T02:37:14ZengBMCClinical Epigenetics1868-70832025-06-0117111710.1186/s13148-025-01900-5A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approachesMeijun Liu0Yuying Wang1Xiaoli Chen2Yu Zeng3Wenqiong Huang4Jiawen Yang5Hong Dai6Lixin Cheng7Claudio Mauro8Kenneth Chat Pan Cheung9Phenome Research Center, Hong Kong Baptist UniversityPhenome Research Center, Hong Kong Baptist UniversityPhenome Research Center, Hong Kong Baptist UniversityPhenome Research Center, Hong Kong Baptist UniversityPhenome Research Center, Hong Kong Baptist UniversitySchool of Life Science, Southern University of Science and TechnologyDepartment of Chemistry, Hong Kong University of Science and TechnologyHealth Data Science Center, Shenzhen People’s Hospital, First Affiliated Hospital of Southern, University of Science and TechnologyCollege of Medicine and Health, University of Birmingham, Queen Elizabeth HospitalPhenome Research Center, Hong Kong Baptist UniversityAbstract Background Glioblastoma multiforme (GBM) is a lethal brain tumor. With the current gold standard chemotherapy treatment, temozolomide (TMZ), many patients do not survive beyond one year. While the urgency of researching novel treatments is understandable, the prohibitively high costs and the prolonged duration of research and clinical trials significantly delay the availability of medical advancements to the general public. This highlights the urgent need for adjuvant therapies to enhance treatment effectiveness. Main body: Recent research has suggested the potential of repurposing FDA-approved drugs such as temozolomide (TMZ), disulfiram (DSF), and aspirin for the treatment of glioblastoma, with encouraging evidence particularly for DSF and aspirin. Additionally, compounds like histone deacetylase inhibitors (e.g., vorinostat) are being investigated for their impact on non-coding RNA (ncRNA) modulation, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). Combining traditional therapies with ncRNA modulation has shown potential in enhancing therapeutic efficacy and targeting specificity. NcRNAs play a crucial role in regulating gene expression and have been implicated in tumor growth, invasion, and treatment resistance. Recent discoveries, such as cuproptosis, offer new insights into tumor cell death mechanisms. Conclusion This review focuses on how these molecular insights can serve as novel therapeutic targets and how drug adjuvant therapy may improve GBM treatment strategies. It focuses on how the integration of ncRNA modulation with conventional therapies and the combination strategy of enhancing efficacy of drugs can enhance treatment efficacy and pave the way for innovative approaches in managing GBM. In short, we will explore how non-coding RNAs (ncRNAs) might serve as promising targets and how repurposing TMZ, DSF, and aspirin could help enhance the efficacy of GBM treatment. Graphical abstracthttps://doi.org/10.1186/s13148-025-01900-5Glioblastoma multiformeTemozolomideDisulfiramCuproptosisAspirinNon-coding RNA |
| spellingShingle | Meijun Liu Yuying Wang Xiaoli Chen Yu Zeng Wenqiong Huang Jiawen Yang Hong Dai Lixin Cheng Claudio Mauro Kenneth Chat Pan Cheung A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches Clinical Epigenetics Glioblastoma multiforme Temozolomide Disulfiram Cuproptosis Aspirin Non-coding RNA |
| title | A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches |
| title_full | A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches |
| title_fullStr | A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches |
| title_full_unstemmed | A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches |
| title_short | A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches |
| title_sort | novel approach to enhance glioblastoma multiforme treatment efficacy non coding rna targeted therapy and adjuvant approaches |
| topic | Glioblastoma multiforme Temozolomide Disulfiram Cuproptosis Aspirin Non-coding RNA |
| url | https://doi.org/10.1186/s13148-025-01900-5 |
| work_keys_str_mv | AT meijunliu anovelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT yuyingwang anovelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT xiaolichen anovelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT yuzeng anovelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT wenqionghuang anovelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT jiawenyang anovelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT hongdai anovelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT lixincheng anovelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT claudiomauro anovelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT kennethchatpancheung anovelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT meijunliu novelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT yuyingwang novelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT xiaolichen novelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT yuzeng novelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT wenqionghuang novelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT jiawenyang novelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT hongdai novelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT lixincheng novelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT claudiomauro novelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches AT kennethchatpancheung novelapproachtoenhanceglioblastomamultiformetreatmentefficacynoncodingrnatargetedtherapyandadjuvantapproaches |